2018 annual financial data
Fulcrum Therapeutics 2018 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -33,498,000 USD and net income was -32,588,000 USD.
Operating cash flow was -22,562,000 USD.
Get free Fulcrum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -33,498,000 USD
- Net income
- -32,588,000 USD
- Operating cash flow
- -22,562,000 USD